|
EMBECTA MEDICAL I LLC - HOLDREGE, NE SYRINGE 0.5ML 31GA 8MM 10 BAG 500 WAL; Syringe, Piston
|
Back to Search Results |
|
| Model Number |
328509 |
| Medical Device Problem Code |
Device Markings/Labelling Problem (2911)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
Pharmacist reported issue on consumers behalf.Stated, there were 15 syringes without scale markings prior to injection.Stated, consumer discarded samples
stated, pharmacy replaced box.Lot: 3352058
catalog: 328509
date of event: unknown
samples: no cl
this intake record was reviewed as part of capas #(b)(4) and #(b)(4) and deficiencies were identified.The following actions were taken fourteen additional complaint records were created for scale marking missing.With these actions completed, this intake record is now consistent with applicable procedures cp62096, cp92021, and regulatory requirements, and separate complaints were opened for each separate event.There was appropriate follow-up (if this was required), and each event is addressed based on the most current information.No further action is required at this time unless new information becomes available.(b)(6) 14-september-2026.
|
| |
|
Additional Manufacturer Narrative
|
|
No samples (including photos) were returned therefore the complaint could not be confirmed and the root cause is undetermined.This is the 21st.Complaint for the reported lot number.A review of the manufacturing records was performed, and no non-conformances were raised in association with this type of event for this lot.Complaints received for this device and reported condition will continue to be tracked and trended.If samples are received in the future the complaint will be reopened for further investigation.Based on the above, no additional investigation and no corrective/preventative action (capa) or situational analysis (sa) is required at this time.This complaint record was reopened/opened and reviewed as part of capas #(b)(4) and #(b)(4).The review revealed that this complaint was determined to be a reportable event.The required activities for reporting this event were completed.The review confirmed that the complaint record is consistent with applicable procedures cp62096, cp92021, and regulatory requirements, and separate complaints were opened for each separate event.There was appropriate follow-up (if this was required), and each event is addressed based on the most current information.There are no additional events or updates that meet the fda mdr reporting requirements.No further action is required at this time unless new information becomes available.(b)(6) 25sep 2026.
|
| |
|
Search Alerts/Recalls
|
|
|